Gemtuzumab ozogamicin: A component of induction therapy in AML?

Francis Giles

Research output: Contribution to a Journal (Peer & Non Peer)Editorial

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalLeukemia Research
Volume29
Issue number1
DOIs
Publication statusPublished - Jan 2005
Externally publishedYes

Cite this